Upside, Downside Movers in the Morning
Upside:
-DY +27% (earnings, guidance; acquires low-voltage engineering and construction firm National Technology Integrators for $275M)
-DTIL +13% (Clinical Data Show PBGENE-HBV Eliminates and Inactivates cccDNA in Liver Biopsies)
-SMTC +13% (earnings, guidance)
-BBWI +11% (earnings, guidance; CFO to resign)
-SPIR +7.1% (signs MoU with Schaeffler to develop space hardware subsystems and satellite platforms)
-CORT +6.0% (plans to resubmit relacorilant NDA for Cushing’s syndrome)
-MANU +4.9% (earnings, guidance)
-ANF +4.5% (earnings, guidance)
-TSM +4.2% (said to increase 3nm chip prices by 15% in H2, 2026)
-MGM +3.7% (JPMorgan Chase and Co Raised MGM to Overweight from Neutral, price target: $46)
-AXTA +3.3% (Akzo Nobel confirms on May 1st rejected conditional cash offer at €73.00/shr from Nippon Paint and Sherwin-Williams)
-APP +3.1% (constructive comments from Morgan Stanley)
-LULU +3.0% (confirms Chip Wilson (Founder) cooperation agreement for ~18 months)
-FLY +2.6% (confirms wins $75M NASA JPL MoonFall Subcontract to Deliver Drones to the Moon’s South Pole; files to sell total of 12M shares of common stock – Firefly offers 4M shares with 8M shares offered by Selling Stockholders)
-BNTX +2.5% (UBS Raised BNTX to Buy from Neutral, price target: $135 from $117)
-HIMS +2.0% (Board member purchases $1.2M of stock)
Downside:
-VRRM -55% (receives Termination of Agreement Notice From Avis Budget Group; Cuts FY guidance)
-ZS -25% (earnings, guidance)
-APGE -11% (discloses data from APEX Phase 2 Part B trial; enters up to $1.3B financing collaboration with Blackstone Life Sciences for zumilokibart)
-GRRR -5.2% (earnings, guidance)
-KMT -5.1% (Barclays Cuts KMT to Underweight from Equal Weight, price target: $33 from $40)
-CPRI -3.8% (earnings, guidance)
-PODD -3.8% (issues voluntary recall for Omnipod Pods that could result in insulin under-delivery)
-DKS -2.6% (earnings, guidance)
Positions: None.
